These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31342551)

  • 1. Fungal melanonychia caused by Candida parapsilosis successfully treated with oral fosravuconazole.
    Noguchi H; Matsumoto T; Kimura U; Hiruma M; Kano R; Yaguchi T; Fukushima S; Ihn H
    J Dermatol; 2019 Oct; 46(10):911-913. PubMed ID: 31342551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of melanonychia due to Candida albicans.
    Parlak AH; Goksugur N; Karabay O
    Clin Exp Dermatol; 2006 May; 31(3):398-400. PubMed ID: 16681587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tinea unguium caused by terbinafine-resistant Trichophyton rubrum successfully treated with fosravuconazole.
    Noguchi H; Matsumoto T; Hiruma M; Kimura U; Kano R; Yaguchi T; Fukushima S; Ihn H
    J Dermatol; 2019 Dec; 46(12):e446-e447. PubMed ID: 31353607
    [No Abstract]   [Full Text] [Related]  

  • 4. Fungal melanonychia.
    Lee SW; Kim YC; Kim DK; Yoon TY; Park HJ; Cinn YW
    J Dermatol; 2004 Nov; 31(11):904-9. PubMed ID: 15729863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of Ravuconazole and its Prodrugs as the New OralTherapeutics for Onychomycosis.
    Yamaguchi H
    Med Mycol J; 2016; 57(4):E93-E110. PubMed ID: 27904057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal melanonychia.
    Finch J; Arenas R; Baran R
    J Am Acad Dermatol; 2012 May; 66(5):830-41. PubMed ID: 22257832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
    Ranawaka RR; Nagahawatte A; Gunasekara TA
    Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug properties of fosravuconazole L-lysine ethanolate (NAILIN
    Nakano M; Aoki Y; Yamaguchi H
    Nihon Yakurigaku Zasshi; 2019; 153(2):79-87. PubMed ID: 30745518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of pathological diagnosis for two cases of candidal onychomycosis].
    Kobayashi K; Sawada M; Ninomiya J; Ishizaki S; Harada T; Tanaka M
    Nihon Ishinkin Gakkai Zasshi; 2009; 50(4):253-7. PubMed ID: 19942797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onychomycosis: Diagnosis and management.
    Singal A; Khanna D
    Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
    Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
    Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients.
    Ranawaka RR; Nagahawatte A; Gunasekara TA; Weerakoon HS; de Silva SH
    J Dermatolog Treat; 2016 Aug; 27(4):364-72. PubMed ID: 26651495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.
    De Doncker P; Decroix J; Piérard GE; Roelant D; Woestenborghs R; Jacqmin P; Odds F; Heremans A; Dockx P; Roseeuw D
    Arch Dermatol; 1996 Jan; 132(1):34-41. PubMed ID: 8546481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole.
    Khosravi AR; Mansouri P
    Mycopathologia; 2001; 150(1):9-13. PubMed ID: 11392568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal melanonychia caused by Fusarium oxysporum in immunocompetent patient.
    Park KY; Lee JW; Kim IS; Suh MK; Choi JS; Moon NJ; Seo SJ
    Mycoses; 2012 Mar; 55(2):e40-1. PubMed ID: 22074386
    [No Abstract]   [Full Text] [Related]  

  • 16. Onychomycosis caused by Fusarium proliferatum.
    Hattori N; Shirai A; Sugiura Y; Li W; Yokoyama K; Misawa Y; Okuzumi K; Tamaki K
    Br J Dermatol; 2005 Sep; 153(3):647-9. PubMed ID: 16120158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence properties and sensitivity profile of Candida parapsilosis complex species and Kodamaea ohmeri isolates from onychomycosis of HIV/AIDS patients.
    Ferreira EO; Mendes INVF; Monteiro SG; Crosara KTB; Siqueira WL; de Maria Pedroso Silva de Azevedo C; Moffa EB; de Andrade Monteiro C
    Microb Pathog; 2019 Jul; 132():282-292. PubMed ID: 31082527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Fingernail Onychomycosis due to Aspergillus flavus.
    Noguchi H; Hiruma M; Miyashita A; Makino K; Miyata K; Ihn H
    Med Mycol J; 2016; 57(2):E21-5. PubMed ID: 27251317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case of onychomycosis due to Candida tropicalis successfully treated using fosravuconazole.
    Harada K; Maeda T
    J Dermatol; 2020 Oct; 47(10):e348-e349. PubMed ID: 32686199
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of Candida isolation from dystrophic fingernails.
    Shemer A; Daniel R; Lyakhovitsky A; Aghion-Svirsky V; Kassem R; Rigopoulos D; Farhi R; Galili E
    Mycoses; 2020 Sep; 63(9):964-969. PubMed ID: 32563206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.